Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8+ T Cells
Join Our Newsletter
Subscribe and stay tuned with the latest news and resources
Our use of cookies
We use cookies on our website. Some of these are essential to provide services you have asked for. We would also like to set the following types of optional cookies:
Analytics Cookies
These cookies help us to improve our website by collecting and reporting information on how you use it.
We won't set optional cookies unless you enable them. For more detailed information on the cookies we use, please see our Cookie Policy